U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898047) titled 'Consistency of Response With Rimegepant in Acute Treatment of Migraine' on March 20.
Brief Summary: This is a non-interventional, prospective study that will enroll participants with migraine in the United Kingdom currently in use of rimegepant to acutely treat migraine attacks. Participants will be followed up for up to 12 weeks and will complete a daily questionnaire to self-report the consistency of response to rimegepant in acute treatment of migraine.
Study Start Date: March 31
Study Type: OBSERVATIONAL
Condition:
Migraine
Intervention:
DRUG: Rimegepant for acute migraine treatment
Rimegepant for acute migraine treatmen...